The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions of dollars annually.
Related Posts
Scott Bessent calls Moody’s a ‘lagging indicator’ after U.S. credit downgrade
The treasury secretary also said he spoke on the phone with Walmart’s CEO, who agreed to absorb some of the costs of Trump’s tariffs.
Putin says Russia backs Ukraine ceasefire but any deal must address ‘root causes’
Russian President Vladimir Putin thanked U.S. President Donald Trump for giving “so much attention” to the prospect of a Russia-Ukraine deal.
Stick to high-quality dividend payers amid tariff turmoil, such as this energy stock, investor Tom Hulick says
Tom Hulick, CEO at Strategy Asset Managers, joined CNBC’s “Power Lunch” to give his opinions on a trio of stocks.